Delivery Order SPE2DB22D2206-SPE2DB25FJD23
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen (2 mL), a pharmaceutical product for military and federal healthcare use. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is registered in the System for Award Management...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,962.95 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/20 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,751.91 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product, with a completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract awarded on July 24, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of the agency's medical supply procurement practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,972.27 on July 31, 2025, by the Defense Logistics Agency for TREMFYA 100 mg/ml, a pharmaceutical product used in the treatment of immunological conditions. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite...
- This is a $12,274.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TREMFYA 100 MG/ML ONE-PRESS syringes, with a period of performance through July 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $43,531.56 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD23Delivery Order
The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by July 30, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military and federal healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to fulfill diverse pharmaceutical requirements through competitive federal procurements has established the company as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/29/25 |